De novo thrombotic microangiopathy in renal allograft biopsies - Role of antibody-mediated rejection

American Journal of Transplantation

Volumn 10, Issue 8, 2010, Pages 1804-1811

  Satoskar, A A ^a   Pelletier, R ^a   Adams, P ^a   Nadasdy, G M ^a   Brodsky, S ^a   Pesavento, T ^a   Henry, M ^a   Nadasdy, T ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Histopathology; HLA antibodies; renal allograft rejection; thrombotic microangiopathy

Indexed keywords

ANTIBODY; COMPLEMENT COMPONENT C4D; CYCLOSPORIN; IMMUNOGLOBULIN G; RITUXIMAB;

ARTICLE; CAPILLARITIS; DISEASE ASSOCIATION; DRUG WITHDRAWAL; GLOMERULITIS; GRAFT FAILURE; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; MICROANGIOPATHY; PLASMAPHERESIS; PREVALENCE; PRIORITY JOURNAL; THROMBOSIS;

BIOPSY; COMPLEMENT C4B; CYCLOSPORINE; GRAFT REJECTION; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; KIDNEY; KIDNEY TRANSPLANTATION; OHIO; PEPTIDE FRAGMENTS; PLASMAPHERESIS; PREVALENCE; RETROSPECTIVE STUDIES; THROMBOTIC MICROANGIOPATHIES;

EID: 77954901670     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03178.x     Document Type: Article

References (24)

1. Copelovitch L, Kaplan BS. The thrombotic microangiopathies. Pediatr Nephrol 2008 23 : 1761 1767.
2. Ponticelli C, Banfi G. Thrombotic microangiopathy after kidney transplantation. Transplant Int 2006 19 : 789 794.
3. Singh N, Gayowski T, Marino IR. Hemolytic uremic syndrome in solid organ transplants. Transplant Int 1996 9 : 68 75.
4. Reynolds JC, Agodoa LY, Yuan CM, Abbott KC. Thrombotic microangiopathy after renal transplantation in the United States. Am J Kidney Dis 2003 42 : 1058 1068.
5. Zarifian A, Meleg-Smith S, O'Donovan R, Tesi RJ, Batuman V. Cyclosporine-associated thrombotic microangiopathy in renal allografts. Kidney Int 1999 55 : 2457 2466.
6. Schwimmer J, Nadasdy T, Spitalnik PF, Kaplan KL, Zand MS. De novo thrombotic microangiopathy in renal transplant recepients: A comparison of hemolytic uremic syndrome with localized renal thrombotic microangiopathy. Am J Kidney Dis 2003 41 : 471 479.
7. Laszik ZG, Silva FG. Hemolytic uremic syndrome, thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. In : Jennette JC, Olson JL, Schwartz MM, Silva FG, eds. Heptinstalls's pathology of the kidney, 6th Ed. Philadelphia: Lippincott Williams & Wilkins, 2007 : 701 764.
8. Karthikeyan V, Parasuraman R, Shah V, Vera E, Venkat KK. Outcome of plasma exchange therapy in thrombotic microangiopathy after renal transplantation. Am J Transplant 2003 3 : 1289 1291.
9. Young BA, Marsh CL, Alpers CE, Davis CL. Cyclosporine-associated thrombotic microangiopathy/hemolytic uremic syndrome following kidney and kidney-pancreas transplantation. Am J Kidney Dis 1996 28 : 561 571.
10. Noel C, Sauneir P, Hazzan M et al. Incidence and clinical profile of microvascular complications in renal allograft patients treated with cyclosporine. Ann Med Interne (Paris) 1992 143 : 33 36.
11. Manzoor K, Ahmed E, Akhtar F, Kazi JI, Naqvi SA, Rizvi SAH. Cyclosporine withdrawal in post-renal transplant thrombotic microangiopathy. Clin Transplant 2006 20 : 43 47.
12. Racusen LC, Colvin RB, Solez K et al. Antibody-mediated rejection criteria- an addition to Banff '97 classification of renal allograft rejection. Am J Transplantation 2003 3 : 708 714.
13. Takemoto SK, Zeevi A, Feng S et al. National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplantation 2004 4 : 1033 1041.
14. Nadasdy GM, Bott C, Cowden D, Pelletier R, Ferguson R, Nadasdy T. Comparative study for the detection of peritubular capillary C4d deposition in human renal allografts using different methodologies. Hum Pathol 2005 36 : 1178 1185.
15. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999 55 : 713 723.
16. Isoniemi HM, Krogerus L, von Willebrand E, Taskinen E, Ahonen J, Häyry P. Histopathological findings in well-functioning, long-term renal allografts. Kidney Int 1992 41 : 155 160.
17. Oritz F, Paavonen T, Törnroth T et al. Predictors of renal allograft histologic damage progression. J Am Soc Nephrol 2005 16 : 817 824.
18. Rocha PN, Butterly DW, Greenberg A et al. Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection. Transplantation 2003 75 : 1490 1495.
19. Jordan SC, Vo AA, Tyan D, Nast CC, Toyoda M. Current approaches to treatment of antibody-mediated rejection. Pediatr Transplant 2005 9 : 408 415.
20. Cicciarelli J, Helstab K, Mendez R. Flow cytometry PRA, a new test that is highly correlated with graft survival. Clin Transplant 1992 6 : 159 164.
21. Gloor JM, Sethi S, Stegall MD. Transplant glomerulopathy. Am J Transplant 2008 8 : 492 496.
22. Martin L, Guignier F, Mousson C, Rageot D, Justrabo E, Rifle G. Detection of donor-specific anti-HLA antibodies with flow cytometry in eluates and sera from renal transplant recipients with chronic allograft nephropathy. Transplantation 2003 76 : 395 400.
23. Gibson IW, Gwinner W, Brcker V et al. Peritubular capillaritis in renal allografts: Prevalence, scoring system, reproducibility and clinicopathological correlates. Am J Transplantation 2008 8 : 819 825.
24. Solez K, Colvin RB, Racusen LC et al. Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplantation 2008 8 : 753 760.